Bydureon and Rituximab and hyaluronidase human, recombinant Subcutaneous
Determining the interaction of Bydureon and Rituximab and hyaluronidase human, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: exenatide
Brand name: Bydureon, Bydureon BCise, Bydureon Pen, Bydureon Tray, Byetta Prefilled Pen
Synonyms: n.a.
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab, Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bydureon-Rituximab Intravenous
- Bydureon-Riva-Amoxicillin
- Bydureon-Rivaroxaban
- Bydureon-Rivastigmine
- Bydureon-Rivastigmine Capsules
- Bydureon-Rivastigmine Oral Solution
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Bydureon (Exenatide Extended-Release Injection (Bydureon) (Pens))
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Bydureon (Exenatide Extended-Release Injection (Bydureon) (Trays))
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Bydureon BCise
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Bydureon Pen
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Byetta
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Bystolic